Evidence map›Paper›PMID 29872961›Full record

ArticleParasitology research2018

Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.

Arutchelvan Rajamanikam, Suresh Kumar, Chandramathi Samudi, Madhav Kudva

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Parasitology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. In vitro Effect of Silver Nanoparticles onInternational journal of nanomedicine · 2020
    Article
  6. Anti-International journal of environmental research and public health · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arutchelvan RajamanikamDepartment of Parasitology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Suresh KumarDepartment of Parasitology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. suresh@um.edu.my.
Chandramathi SamudiDepartment of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Madhav KudvaGastroenterology and Hepatology Specialist Clinic, Pantai Hospital, Kuala Lumpur, Malaysia.

Funding

Fundamental Research Grant Scheme (FRGS) FP015-2017APostgraduate Research Grant (PPP) PG140-2016A
6 · The paper itself

Abstract

Blastocystis sp. is a gastrointestinal (GI) protozoan parasite reported to cause non-specific GI symptoms including diarrhea, flatulence, abdominal pain, and nausea. Complete eradication of Blastocystis sp. is rather challenging even with the drug of choice, i.e., metronidazole. Here, we report on two Blastocystis sp.-infected individuals, who presented increased parasite load and exacerbated symptoms upon treatment with the usual recommended dosage and regime of metronidazole. The two studies uniquely demonstrate for the first time a cyst count as high as fivefold more than the original cyst count before treatment and show an exacerbation of GI symptoms despite treatment. The study provides additional support in recognizing metronidazole resistance in Blastocystis sp. and its consequences towards the pathogenicity of the parasite.

Indexed as

AdolescentAdultAnimalsAntiprotozoal AgentsBlastocystisBlastocystis InfectionsDrug ResistanceGastrointestinal DiseasesHumansIntestinal Diseases, ParasiticMaleMetronidazoleAntiprotozoal AgentsMetronidazoleBlastocystis sp.CystsExacerbation of symptomsMetronidazoleSubtypes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.